P104 Upregulation of both APRIL and BAFF in systemic lupus erythematosus suggests non-redundant roles, further revealed by potent dual inhibition with povetacicept (TACI vTD-Fc; ALPN-303)

• Amanda Enstrom,
• Elizabeth Repash,
• Ismail Simsek,
• Stanford L Peng,
• Katherine E Lewis,
• Zahra Maria,
• Tiffany C Blair,
• Lawrence S Evans,
• Armand Bankhead,
• Stacey R Dillon

Affiliations

Amanda Enstrom

Aff1 grid.417411.6Aduro BioTech, Inc. Berkeley CA USA

Elizabeth Repash

1 Bicycle Therapeutics, 4 Hartwell Place, Lexington, Massachusetts, USA

Ismail Simsek

Gulhane Military School of Medicine, Division of Rheumatology, Ankara, Turkey

Stanford L Peng

Alpine Immune Sciences, Seattle, WA, USA

Katherine E Lewis

Alpine Immune Sciences, Seattle, WA, USA

Zahra Maria

Alpine Immune Sciences, Seattle, WA, USA

Tiffany C Blair

Alpine Immune Sciences, Seattle, WA, USA

Lawrence S Evans

Alpine Immune Sciences, Seattle, WA, USA

Armand Bankhead

Alpine Immune Sciences, Seattle, WA, USA

Stacey R Dillon

Alpine Immune Sciences, Seattle, WA, USA